Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
43 Leser
Artikel bewerten:
(0)

Kenes Group to Manage Event with Potential to Change the Future of Diabetes Care and Research: 3rd World Congress on Interventional Therapies for Type 2 Diabetes: WCITT2D 2015

GENEVA, Switzerland, Sept. 27, 2015 /PRNewswire/ --Kenes Group Ltd., a leading Professional Conference Organizer (PCO) and Association Management company, today announced that it will host two important industry events: 3rd World Congress on Interventional Therapies for Type 2 Diabetes (WCITT2D 2015) being held in conjunction with the 2nd Diabetes Surgery Summit (DSS-II), that will take place 28-30 September 2015 in London at the Westminster Park Plaza Hotel. The Congress and Summit are hosted by King's College London and are organized in partnership with world-leading diabetes organizations. Two seminal events in one, the congress is an unprecedented gathering to review the latest research in metabolic surgery and to develop new guidelines for the development of a modern, multi-modality approach to the care of type 2 diabetes.

This influential event will examine the significant role of bariatric/metabolic surgery in improving the management and understanding of type 2 diabetes. A comprehensive review of the science behind this approach will include the latest results of long-term randomized clinical trials, including late-breaking studies presented for the first time and the newest findings on the fascinating mechanisms of action in metabolic surgery. Clinical Sessions will also feature a comprehensive review and discussion of the latest studies on the effects of surgery on glycemic control and cardiovascular risk in patients with T2DM, including in those with lower BMI and in adolescents. World leading scientists will also review current evidence on the functioning of the gastrointestinal tract and its role in the physiology and pathophysiology of glucose homeostasis.

"The advanced scientific program will be coupled with an unparalleled opportunity for attendees to participate in the evaluation of new guidelines and recommendations for the surgical treatment of diabetes," comments Prof. Francesco Rubino, MD, Congress Chair, Chair, Bariatric and Metabolic Surgery King's College London.

"Attending the 3rd World Congress & DSS-II is a unique opportunity to be a part of and witness history and we invite medical professionals and clinicians to join the world's leading experts and policy makers in this ground-breaking endeavor. More importantly, this is not a specialized surgical conference nor an endocrinology conference, but rather the only forum in the world that brings together physicians, surgeons, basic scientists, industry leaders, and policy makers, while also representing the perspective of patients," he added.

Prof. David e. Cumming, DSS Co-Director, Division of Metabolism, Endocrinology and Nutrition, University of Washington, states "Cutting-edge evidence related to bariatric/metabolic surgery will be presented and used to generate new, modern guidelines for the use and study of gastrointestinal surgery to treat diabetes, obesity, and other metabolic diseases. We welcome you to witness and participate in this historic event".

The 3rd World Congress was established to address the challenges and seize the opportunities that surgery offers to diabetes care and research. It is an international forum where a stellar faculty of clinicians, scientists, and policy makers discuss available evidence on the use and study of bariatric/metabolic surgery and new device-based intervention. The overarching aim of the congress is to craft an agenda of research priorities and health policy initiatives. The consensus portion of the meeting (DSS-II) will be attended by global policy-makers and organized in partnership with the American Diabetes Association (ADA), the European Society for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), Diabetes UK, Chinese Diabetes Society and Diabetes India.

To register and for more information, visit the congress website: www.wcitt2d.org.

About Kenes Group
Fifty years of knowledge, experience and market expertise have led Kenes Group to the forefront of global conference management and to becoming one of the world's leading Professional Conference Organizers (PCOs). Founded in Tel Aviv in 1965 and headquartered in Geneva and Tel Aviv, Kenes has hosted over 3,000 conferences in more than 100 cities around the globe, with over 115,000 participants per year. Recognized as the world leader in meeting planning, Kenes is the only global PCO dedicated to medical and scientific events. Kenes boasts a team of over 300 professional, multi-cultural, multi-disciplinary employees in 16 Kenes offices on four continents, with more than 100 returning and long term clients. For more information, visit the website at: www.kenes-group.com.

For more information, contact:
Rachel Zeevy, Congress Secretariat
Tel. +41 22 9080488 Ext. 525
Email. rzeevy@kenes.com

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.